secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2026-08-18T12:30:29+00:00
Accession:  0001493152-26-038897
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

bioAffinity signs distribution agreement with AvMEDICAL for CyPath Lung in federal healthcare
--------------------------------------------------------------------------------

- Distribution agreement with AvMEDICAL (SDVOSB) to market CyPath Lung to federal agencies, including VA medical centers.
- AvMEDICAL's sales force and IDIQ contract access expected to expand government procurement of CyPath Lung.
- CyPath Lung clinical data: 92% sensitivity, 87% specificity, 88% accuracy, 99% NPV in high-risk patients with nodules <20mm.
- VA context: ~8,000 veterans diagnosed with lung cancer annually; ~5,000 die; early detection goal.
- Co-branded marketing and AvMEDICAL promotion to federal customers; no financial terms disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226038897/0001493152-26-038897-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226038897/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-038897

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer